Table 1.
Losses% | Gains% | Total% | ||||
---|---|---|---|---|---|---|
average | range | average | range | average | range | |
HPV16 (n = 16) | 2.19% | 0.005-9.82% | 9.18% | 0.028-43.33% | 11.37% | 0.19-43.91% |
HPVnon16 (n = 27) | 6.65% | 0.015-37.75% | 9.49% | 0.015-37.75% | 16.14% | 0.12-54.04% |
HPV31 (n = 14) | 6.67% | 0.015-37.75% | 11.64% | 0.081-31.40% | 18.31% | 0.20-46.46% |
HPVα9 (n = 35) | 4.20% | 0.005-37.75% | 9.38% | 0.028-43.33% | 13.58% | 0.19-46.46% |
HPVα5+α7 (n = 8) | 8.45% | 0.093-36.60% | 9.36% | 0.025-30.18% | 17.80% | 0.12-54.04% |
Shown are the average percentage and the range of deviating array oligonucleotides. An increased amount of aberrations can be seen in the lesions with types other than HPV16